Clinical Trial Update: A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Lianxiaxiaopi Granules for postprandial distress syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postprandial Distress Syndrome

Drugs mentioned

• Lianxiaxiaopi Granules

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Postprandial Distress Syndrome | Phase 3 | Status: RECRUITING